摘要
背景:近年来的研究发现雷公藤甲素具有很好的抗排异、抗肿瘤作用。PG490-88是雷公藤甲素的提取物,能够预防移植物抗宿主病和诱导免疫耐受。目的:探讨雷公藤甲素PG490-88联合环孢素A在大鼠肾移植急性排斥反应中诱导免疫耐受的作用。方法:改良法建立大鼠肾移植动物模型。40只Wistar大鼠做供体、40只SD大鼠做受体,随机数字表法均分为4组:对照组给予常规饮食。雷公藤甲素组给予雷公藤甲素PG490-8820mg/(kg·d)灌胃。环孢素A组给予环孢素A15mg/(kg·d)灌胃;联合治疗组:PG490-8820mg/(kg·d)+环孢素A15mg/(kg·d)灌胃。分别检测肾移植后各组1,3,5,7,14d外周血白细胞介素2受体水平和肾移植后大鼠的脾脏淋巴细胞组织中的白细胞介素2活性蛋白表达。结果与结论:3个治疗组的白细胞介素2活性和白细胞介素2受体均明显低于对照组(P<0.05)。其中,联合治疗组低于雷公藤甲素组和环孢素A组,差异有显著性意义(P<0.05)。提示,雷公藤甲素PG490-88通过对白细胞介素2、白细胞介素2受体的影响,来达到免疫抑制作用,不但具有免疫抑制作用,而且还能够诱导一定程度的免疫耐受,联合环孢素A效果会更好。
BACKGROUND:Studies demonstrated that triptolide has good effect on anti-rejection and anti-tumor. PG490-88 is extracted from triptolide,which can prevent graft versus host disease and induce immune tolerance. OBJECTIVE:To investigate the effect of PG490-88 combined with ciclosporin A on inducing immune tolerance in a rat renal allograft rejection model. METHODS:Kidney transplantation models were constructed using improved method. Forty Wistar rats served as donors,and 40 SD rats served as recipients. All rats were randomly divided into 4 groups. Rats were regular raised in the control group. Rats were lavaged with triptolide PG490-88 [20 mg/(kg·d)],ciclosporin A [15 mg/(kg·d)] or PG490-88 [20 mg/(kg·d)]+ ciclosporin A [15 mg/(kg·d)] in the PG490-88,ciclosporin A or the combination group. Serum levels of interleukin 2-receptor (IL-2R) and activity of IL-2 in spleen lymph cells were detected respectively at 1,3,5,7 and 14 days after transplantation. RESULTS AND CONCLUSION:Serum levels of IL-2R and activity of IL-2 were detected lower in 3 treated groups than those in the control group (P 0.05). Among the 3 treated groups,the combination group was lower than that of the PG490-88 and ciclosporin A groups (P 0.05). Triptolide PG490-88 performs its function of immunosuppressant on the liver transplantation through IL-2 and IL-2R. It is not only has immunosuppressive action,but also can induce immune tolerance,the effects would be better when combined with ciclosporin A.
出处
《中国组织工程研究与临床康复》
CAS
CSCD
北大核心
2011年第5期861-864,共4页
Journal of Clinical Rehabilitative Tissue Engineering Research
基金
深圳市科技计划项目基金(200903038)~~